Page last updated: 2024-10-30

meclofenoxate and Hepatic Encephalopathy

meclofenoxate has been researched along with Hepatic Encephalopathy in 1 studies

Meclofenoxate: An ester of DIMETHYLAMINOETHANOL and para-chlorophenoxyacetic acid.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FUKASE, M1
TSUNEMATSU, T1
NISHIYA, Y1
SHINOBE, N1
NAKAGAWA, J1
MIURA, K1
KIDO, H1
IMOTO, T1
KATAYAMA, H1
KONDO, T1
MORITA, A1

Other Studies

1 other study available for meclofenoxate and Hepatic Encephalopathy

ArticleYear
[CLINICAL EXPERIENCE WITH CENTROPHENOXINE (T-119) IN INTERNAL MEDICINE].
    No to shinkei = Brain and nerve, 1964, Volume: 16

    Topics: Amyotrophic Lateral Sclerosis; Biomedical Research; Brain Diseases; Central Nervous System Stimulant

1964